Next Article in Journal
Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients
Next Article in Special Issue
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
Previous Article in Journal
Editorial for the Specific Issue: “Lipid-Based Nanocarriers”
Previous Article in Special Issue
Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Biomedicines 2022, 10(7), 1735; https://doi.org/10.3390/biomedicines10071735
Action Date Notes Link
article xml file uploaded 19 July 2022 09:24 CEST Original file -
article xml uploaded. 19 July 2022 09:24 CEST Update https://www.mdpi.com/2227-9059/10/7/1735/xml
article pdf uploaded. 19 July 2022 09:24 CEST Version of Record https://www.mdpi.com/2227-9059/10/7/1735/pdf
article html file updated 19 July 2022 09:36 CEST Original file -
article html file updated 13 August 2022 02:27 CEST Update https://www.mdpi.com/2227-9059/10/7/1735/html
Back to TopTop